We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MEDIC.AT

Price
2.58
Stock movement up
+0.01 (0.39%)
Company name
Medicon Hellas S.A.
Exchange
(AT
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
11.40M
Ent value
-
Price/Sales
0.55
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
4.50
Forward P/E
-
PEG
-
EPS growth
-
1 year return
24.64%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

MEDIC.AT does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E4.50
Price to OCF7.59
Price to FCF28.74
Price to EBITDA3.88
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.55
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count4.42M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash0.00
Net receivables9.91M
Total current assets22.85M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets0.00
Accounts payable1.61M
Short/Current long term debt0.00
Total current liabilities4.30M
Total liabilities0.00
Shareholder's equity0.00
Net tangible assets16.97M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.57
Daily high2.59
Daily low2.56
Daily Volume10K
All-time high23.85
1y analyst estimate-
Beta0.60
EPS (TTM)-
Dividend per share0.00
Ex-div date10 Jul 2023
Next earnings date-

Downside potential

Loading...
Downside potential data
MEDIC.ATS&P500
Current price drop from All-time high-89.18%-1.08%
Highest price drop-91.78%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-90.19%-2.64%
Avg time to new high-6 days
Max time to new high294 days89 days
COMPANY DETAILS
MEDIC.AT (Medicon Hellas S.A.) company logo
Marketcap
11.40M
Marketcap category
Small-cap
Description
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calibration materials, and tests. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications, and supplies IT systems to healthcare providers. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. Medicon Hellas S.A. was founded in 1988 and is headquartered in Gerakas, Greece.
Employees
180
Investor relations
-
CEO
Country
Greece
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025